miR-455 Inhibits the Viability and Invasion by Targeting RAB18 in Hepatocellular Carcinoma

Chenghong Wang1, Guicai Zhu2, Miaolin Yu3

  • 1Department of Clinical Laboratory, Yantaishan Hospital, Yantai 264000, China.

Journal of Oncology
|June 17, 2021
PubMed
Abstract